Teaching teens with heart defects to take charge: a program aims to ease the leap to adult care
NCT ID NCT03005626
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a therapeutic education program helps teenagers and young adults with congenital heart disease transition from pediatric to adult medical care. Participants aged 13 to 25 will either receive the education program or standard follow-up. Researchers will measure changes in quality of life over one year using a standard questionnaire.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- therapeutic education program
- What this could lead to
- If effective, this program could become a standard way to help teens with congenital heart disease manage their own health and maintain a better quality of life as adults.
- What could go wrong
- This is a relatively small study testing a behavioral program, not a drug. The results may not apply to all patients or settings, and the program may not lead to lasting improvements.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
200 people
The number who actually took part.
- Started
-
Jan 2017
- Finished
-
Nov 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
13 to 25 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient from 13 years to 25 years inclusive. * Carrying of Congenital Heart Disease as defined in the International Classification. * Possible follow-up for one year on one of the three hospital center. * Informed consent of the patient for adults and, parents or legal guardians for minors. * Affiliation to a social security system. Exclusion Criteria: * Non-francophone, * Severe intellectual impairment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Congenital heart diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pediatric and Congenital Cardiology and Pulmonology Department, Arnaud De Villeneuve University Hospital
Montpellier, 34295, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.